dc.contributor.author | Niyigena, Philomene | |
dc.date.accessioned | 2023-06-29T09:42:26Z | |
dc.date.available | 2023-06-29T09:42:26Z | |
dc.date.issued | 2022 | |
dc.identifier.uri | http://hdl.handle.net/123456789/2005 | |
dc.description | Master's Dissertation | en_US |
dc.description.abstract | This study intended to find the impact of risk management on the performance of pharmaceutical investment companies operating in Rwanda. The specific objectives were to explore risks facing pharmaceutical investment companies and their management strategies; to analyse the financial performance of pharmaceutical investment companies and to find the relationship between risks management and the performance of pharmaceutical industry. The study used a survey research design and data was collected from one of the pharmaceutical businesses companies operating in Rwanda. Data was analyzed using SPSS. The study revealed that pharmaceutical investment companies operating in Rwanda face several risks in their operations due to environments, the quality of facilities that are put in place and the business structure that rely on product shipment incite probable risks. Much expired products to the reduction in demand that led to the accumulated loss in business. Thus, the effectiven | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Rwanda | en_US |
dc.subject | Risks management; financial performance | en_US |
dc.title | Investment risk management and financial performance of pharmaceutical companies in Rwanda | en_US |
dc.type | Dissertation | en_US |